CheckMate 037: Nivolumab Improved Responses, Not Survival in Advanced Melanoma

Patients with advanced melanoma treated with nivolumab had higher and more durable responses compared with investigator ’s choice of chemotherapy, but these increases did not result in improved survival outcomes.

Source: CancerNetwork - July 17, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Melanoma News Source Type: news